Primary thrombophilia in México VII: the V617F mutation of JAK2 is not a frequent cause of thrombosis

By Garcés-Eisele Javier   González-Carrillo Martha L.   Reyes-Núñez Virginia   Ruiz-Argüelles Guillermo J.  

Hematology, Vol. 13, Iss. 4, 2008-08 ,pp. : 244-246

Maney Publishing

Access to resources Recommend Favorite

Clinical significance of V617F mutation of the JAK2 gene in patients with chronic myeloproliferative disorders

By Basquiera Ana L.   Soria Néstor W.   Ryser Ricardo   Salguero Miriam   Moiraghi Beatriz   Sackmann Federico   Sturich Ana G.   Borello Adriana   Berretta Adriana   Bonafé Miriam   Barral José Moreno   Palazzo Emilio D.   García Juan J.  

Hematology, Vol. 14, Iss. 6, 2009-12 ,pp. : 323-330

Maney Publishing

Access to resources Recommend Favorite

Real‐Time PCR and Droplet Digital PCR: two techniques for detection of the JAK2V617F mutation in Philadelphia‐negative chronic myeloproliferative neoplasms

By  

International Journal Of Laboratory Hematology, Vol. 37, Iss. 6, 2015-12 ,pp. : 766-773

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of JAK2V617F mutation on thrombosis and myeloid transformation in essential thrombocythemia: a multivariate analysis by Cox regression in 141 patients

By Chim C. S.   Sim J. P.   Chan C. C.   Kho B. C.   Chan J. C.   Wong L. G.   Law M.   Liang R.   Kwong Y. L.  

Hematology, Vol. 15, Iss. 4, 2010-08 ,pp. : 187-192

Maney Publishing

Access to resources Recommend Favorite

JAK2 46/1 haplotype is associated with JAK2 V617F – positive myeloproliferative neoplasms in Brazilian patients

By  

International Journal Of Laboratory Hematology, Vol. 37, Iss. 5, 2015-10 ,pp. : 654-660

John Wiley & Sons Inc

Access to resources Recommend Favorite